Practical guide · Opening your capital
A fundraising is negotiated on two fronts: price and rights. The price sets the dilution. The rights (governance, reserved matters, exit terms, the founder’s commitments) set your room for manoeuvre for as long as the investor stays. An owner-manager who puts the company in order before meeting investors and reads the shareholders’ agreement as closely as the valuation keeps control of what matters.
The figure everyone talks about is the valuation. The one that will weigh on your day-to-day is elsewhere: in the list of decisions you will no longer be able to take alone, in the terms on which the investor will be able to exit and in the personal commitments you will be asked to sign. An investor who accepts a high valuation readily makes up for it in the rights attached to its shares. Price and rights are negotiated together, at the letter of intent stage.
The investor will read your registers before your projections. It will check that every shareholder can trace their shares to a deed, that the accounts have been approved and filed, that the articles reflect every past decision and that the company actually owns what it uses: trade mark, software, domain name. Every irregularity found in due diligence comes back as a condition precedent, a specific indemnity or a price reduction. Fixing it beforehand costs less than negotiating it afterwards. That is what the firm’s corporate health check is for.
The letter of intent, or term sheet, does not bind the parties to conclude, except, as a rule, for its exclusivity and confidentiality clauses. It nonetheless frames everything that follows: amount, pre-money valuation, instrument, board composition, reserved matters, exit clauses, warranties. A point conceded at this stage is hard to reopen once the investor has incurred its due diligence costs. The term sheet should be reviewed with your lawyer before it is signed.
In an established company, the investor most often subscribes for new shares, ordinary or preference shares. Preference shares (Article L. 228-11 of the French Commercial Code) carry special rights defined in the articles: priority dividend, adjusted voting rights, priority on exit proceeds. They exist only in companies limited by shares. An SARL that wants to bring in a fund first converts into an SAS.
Securities giving access to the share capital (Article L. 228-91) defer the investor’s entry into the capital: share warrants, convertible bonds. For a first round, the BSA AIR (a French share warrant comparable to a SAFE) lets the company collect funds immediately and defer the valuation to the next round, with a discount and often a valuation cap. It is quick to sign. The actual dilution, however, remains unknown until conversion, and a poorly calibrated cap makes it heavier than expected.
A minority investor wants a say in whatever affects the value of its investment: new share issues, borrowing above a threshold, disposals of significant assets, management pay, the annual budget. The list of reserved matters is negotiated line by line. Drawn too broadly, it pushes day-to-day management up to a committee.
The investor comes in to get out one day. The shareholders’ agreement organises its exit and often governs yours: a temporary lock-up of the founders’ shares, a right of first refusal, a tag-along right if you sell, a drag-along obligation if an offer for the entire share capital is accepted by a defined majority. In an SAS, a lock-up clause in the articles is limited to ten years (Article L. 227-13) and can only be adopted unanimously (Article L. 227-19).
Financial clauses come on top. The liquidation preference pays the investor first out of the sale proceeds. The anti-dilution clause protects it if a later round takes place at a lower valuation. Their effect only shows at exit, in the price you receive.
The founder usually gives representations about the company, sometimes a warranty against undisclosed liabilities in favour of the investor. They undertake to devote their working time to the company and not to compete with it. Above all, they accept leaver clauses: if they leave office, their shares may have to be sold, at a price that depends on the circumstances of the departure (good leaver, bad leaver). These clauses affect your personal wealth. Their duration, the applicable price and the definition of leaver events deserve as much time as the valuation.
In an SAS, a capital increase is a collective decision of the shareholders, taken under the conditions set by the articles (Article L. 227-9). In an SARL, amendments to the articles require the majorities set by Article L. 223-30. In an SAS, where the issue is reserved for a named investor, the shareholders’ preferential subscription right is waived in its favour: if the investor is already a shareholder, it does not vote and its shares are excluded from the quorum and majority calculation; the issue price is set on the report of a statutory auditor, appointed for the purpose if the company has none (Article L. 225-138). That appointment needs to be built into the timetable.
Between the term sheet and completion, due diligence, drafting and negotiating the documents take several weeks. On completion day, subscription, payment of the funds, recording of the capital increase, updating of the articles and signature of the shareholders’ agreement follow one another in an order set in advance. The formalities come afterwards.
Yes, through an issue of new shares (parts sociales) by way of a capital increase decided by the majorities of Article L. 223-30. An SARL cannot issue preference shares or securities giving access to the capital. Investment funds therefore usually ask for a conversion into an SAS before coming in.
In practice, yes. The agreement is signed at completion, at the same time as the subscription. The articles are amended on the same day for the provisions that must appear in them, such as the rights attached to preference shares.
No. The number of shares it gives access to is determined at the next round, by applying the discount and, if there is one, the valuation cap. The contract must also provide for what happens if no round takes place before maturity or if the company is sold in the meantime.
It can block what the articles and the shareholders’ agreement allow it to block: reserved matters and decisions for which the required majority gives it a blocking minority. Everything turns on how the list is drafted.
See also: the shareholders’ agreement; the corporate health check; the share sale
Preparing a fundraising?
Describe the company, the amount sought and where discussions with investors stand: the firm will reply within 48 business hours.
Mickaël Labigne, avocat, admitted to the New York and Paris Bars. About the firm.
Last updated: 2 November 2026.
This information is general and does not constitute legal advice. Every transaction calls for its own analysis.